Wolds Medical Limited - Filleted accounts

Registered number

12937026

Wolds Medical Limited

(formerly Illumina Diagnostics Limited)

Filleted Accounts

30 September 2025

Wolds Medical Limited
Registered number:		12937026
Balance Sheet
as at 30 September 2025

Notes			2025			2024
£				£
Fixed assets
Tangible assets	3		99,534			156,722

Current assets
Debtors	4	10,594			165,085
Cash at bank and in hand		73,305			613,031
		83,899			778,116

Creditors: amounts falling due within one year	5	(146,919)			(758,353)

Net current (liabilities)/assets			(63,020)			19,763

Total assets less current liabilities			36,514			176,485


Provisions for liabilities			(24,883)			(39,180)


Net assets			11,631			137,305

Capital and reserves
Called up share capital			100			100
Profit and loss account			11,531			137,205

Shareholders' funds			11,631			137,305

The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




S Peart
Director
Approved by the board on 8 June 2026

Wolds Medical Limited
Notes to the Accounts
for the period from 1 April 2024 to 30 September 2025


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts. Turnover includes revenue earned from the rendering of services and is recognised according to the date on which the services are provided.

	Tangible fixed assets
	Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

	Medical equipment	25% reducing balance
	Office equipment	25% reducing balance
	Motor vehicles	25% reducing balance

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price).

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Provisions
	Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.

	Leased assets
	Operating lease payments are recognised as an expense on a straight line basis over the lease term.

	Pensions
	Contributions to defined contribution plans are expensed in the period to which they relate.


2	Employees			2025		2024
Number					Number

	Average number of persons employed by the company			13		12


3	Tangible fixed assets
		Medical and office equipment		Motor vehicles		Total
£			£		£
	Cost
	At 1 April 2024	142,285		109,263		251,548
	Additions	2,539		-		2,539
	At 30 September 2025	144,824		109,263		254,087

	Depreciation
	At 1 April 2024	67,760		27,066		94,826
	Charge for the period	28,904		30,823		59,727
	At 30 September 2025	96,664		57,889		154,553

	Net book value
	At 30 September 2025	48,160		51,374		99,534
	At 31 March 2024	74,525		82,197		156,722


4	Debtors			2025		2024
£					£

	Trade debtors			770		144,588
	Other debtors			9,824		20,497
				10,594		165,085


5	Creditors: amounts falling due within one year			2025		2024
£					£

	Trade creditors			22,358		30,933
	Taxation and social security costs			6,301		146,356
	Other creditors			118,260		581,064
				146,919		758,353


6	Related party transactions

	During the year dividends were paid to the shareholding directors of £NIL (2024: £430,000).

	The balance owed to the directors was £110,626 (2024: £540,626) at the year end.

7	Controlling party

	The company is a wholly owned subsidiary of Wolds Medical Group (Holdings) Limited.

	During the accounting period the entire share capital of Wolds Medical Limited (formerly Illumina Diagnostics Limited) was acquired by Wolds Medical Group (Holdings) Limited.


8	Other information

	Wolds Medical Limited is a private company limited by shares and incorporated in England. Its registered office is:

	31 Abbey Road
	Grimsby
	North East Lincolnshire
	DN32 0HQ